 Home > Chemicals Industry > China Chemical > A new round of prosperity for the pharmaceutical equipment industry has arrived, and the pattern is expected to be optimized

A new round of prosperity for the pharmaceutical equipment industry has arrived, and the pattern is expected to be optimized

 Last Update: 2022-02-22
 Source: Internet
 Author: User

Tags

pharmaceutical

puerto rico pharmaceutical

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

[ Market Analysis of Chemical Machinery Equipment Network ] Since 2020, domestic pharmaceutical equipment and vaccine production orders have ushered in a significant increase, and many domestic pharmaceutical machine manufacturers have gained opportunities.
The foreseeable increase in monoclonal antibody drugs is expected to be about 10.
5 billion yuan.
It can be said that a new round of prosperity for the pharmaceutical machine industry has arrived
.
At the same time, coupled with the increase in R&D investment of domestic pharmaceutical machine giants, the industry is also accelerating its upgrade, and the future industry pattern is expected to be optimized
.

Chemical Machinery Equipment Network Market Analysis Chemical Machinery Equipment

A new round of prosperity for the pharmaceutical machine industry has arrived

In recent years, with the aging of the population and the enhancement of patients' health awareness, the demand for medicine has continued to grow, coupled with the normalization of centralized procurement and the promotion of the new version of the medical insurance catalog, more and more antibody drug industries have entered a stage of rapid development
.
Data shows that in the entire biological drug market, the monoclonal antibody industry is expected to maintain rapid growth.
It is expected that the scale of China's monoclonal antibody industry will maintain a compound growth rate of 58.
33% from 2019 to 2023
.

　　Under the new situation, the group-based pharmaceutical companies continue to integrate the industry and accelerate the construction of new production capacity.
The demand for equipment renewal and transformation is also increasing, and the entire pharmaceutical machine industry has ushered in a new round of prosperity
.
Data show that in 2020, the total revenue of the pharmaceutical special equipment manufacturing industry is 19.
7 billion yuan, a year-on-year increase of 14.
6%; the total profit is 1.
275 billion yuan, a year-on-year increase of 145.
7%
.

　　At the same time, since 2019, the investment in fixed assets of pharmaceutical companies has continued to increase, driving the revenue and profit of the pharmaceutical equipment industry to rebound
.
Data show that by the end of 2020, the asset scale of the pharmaceutical special equipment industry reached 30.
2 billion yuan, a significant year-on-year increase
.

Pharmaceutical equipment

　　In addition, data show that the number of pharmaceutical companies in China increased by 549 in the six years from 2015 to 2020, showing a growing trend
.
By the end of 2020, the number of pharmaceutical manufacturing enterprises in China reached 7,665, a year-on-year increase of 3.
8%
.
And entering 2021, the camp of pharmaceutical companies is still expanding, and it has increased to 8,228 by February, which will also bring more development opportunities to the pharmaceutical equipment market
.
In the future, with the approval of a large number of clinical products, the demand for pharmaceutical equipment from related companies will increase
.
In general, the pharmaceutical equipment industry has ushered in a new round of economic cycle
.

　　The industry structure is expected to be optimized

　　In the past, due to the consumption concept of pharmaceutical factories and other reasons, the competitiveness of domestic equipment in the high-end market was weak.
Since 2020, due to the problem that the delivery time of imported equipment cannot meet the requirements of domestic vaccine manufacturers, and some domestic pharmaceutical machine giants have previously The import substitution in the high-end market of vaccines and other products has been deployed, which has brought a significant increase in domestic pharmaceutical equipment and vaccine production orders, and many domestic pharmaceutical machine manufacturers have ushered in opportunities.
100 million yuan, and the expected increase of monoclonal antibody drugs is about 10.
5 billion yuan
.

　　At the same time, with the fierce competition in the domestic pharmaceutical equipment market and serious product homogeneity, the domestic pharmaceutical machinery industry is also accelerating its upgrade.
For example, domestic pharmaceutical machinery enterprises represented by Chutian Technology and Tofflon have shown a trend of high investment in research and development in recent years.
, While laying out product research and development and improving product performance, the business scope is also continuously expanding, developing towards a multi-category and intelligent overall solution provider, and the competitive landscape is improving
.

　　The "14th Five-Year Plan" mentioned that it is necessary to further guide enterprises to break through core technologies, rely on major scientific and technological projects, special projects for high-quality development of manufacturing industries, etc.
to strengthen key core technologies and product research, strengthen international cooperation in the field of technology, and effectively solve the problem of "stuck neck" "Problems, provide strong support for building a modern economic system and achieving high-quality economic development
.
The industry predicts that in the future, driven by the "14th Five-Year Plan", the development of domestic pharmaceutical equipment will be accelerated, the pace of import substitution will be accelerated, and the industry structure will be further optimized
.

　　At present, the industry is generally optimistic about the development prospects of the pharmaceutical equipment industry
.
For example, Dongxing Securities released a research report on June 27 saying that it was the first to give Chutian Technology a strong recommendation rating
.
The reasons for the rating mainly include: downstream fixed asset investment has accelerated, and a new round of prosperity in the pharmaceutical equipment industry has arrived; the localization of biopharmaceutical equipment can be expected, and the pharmaceutical equipment industry structure will be optimized; investment rating
.

　　Original title: A new round of prosperity for the pharmaceutical equipment industry has arrived, and the pattern is expected to be optimized

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.